Stereotactic Body Radiotherapy (SBRT) or Surgery in Early Stage (I & II) Non Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Koyi, Hirsh [1 ]
Hillerdal, Gunnar [2 ]
Friesland, Signe [3 ]
Kolbeck, Karl Gustav [2 ]
Andersson, Olov [2 ]
Bergman, Per [4 ]
Orre, Lotta [4 ]
Liv, Per [5 ]
Branden, Eva [1 ]
机构：
[1] Gavle Cent Hosp, Dept Resp Med, S-80187 Gavle, Sweden
[2] Karolinska Univ Hosp, Dept Resp Med, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Thorac Surg, Stockholm, Sweden
[5] Uppsala Univ, Ctr Res & Dev, Cty Council Gavleborg, Gavle, Sweden
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
early stage; Surgery; stereotactic body radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.02-041
引用
收藏
页码：S566 / S566
页数：1
相关论文
共 50 条
  • [21] Stereotactic body radiotherapy for stage I non-small cell lung cancer
    Martel-Lafay, I.
    [J]. ONCOLOGIE, 2012, 14 (05) : 282 - 288
  • [22] STEREOTACTIC BODY ABLATIVE RADIOTHERAPY FOR STAGE I NON SMALL CELL LUNG CANCER
    Beltramo, G.
    Bergantin, A.
    Martinotti, A.
    Bonfanti, P.
    Bianchi, L. C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S570 - S571
  • [23] Stereotactic body radiotherapy for early stage non-small cell lung cancer
    Lagerwaard, F.
    [J]. LUNG CANCER, 2012, 77 : S9 - S10
  • [24] Stereotactic body radiotherapy for stage I non-small cell lung cancer
    Slotman, Ben J.
    [J]. JOURNAL OF RADIOSURGERY AND SBRT, 2011, 1 (01): : 63 - 69
  • [25] Predictors of Lung Fibrosis after Stereotactic Body Radiation Therapy (SBRT) for Stage I-II Non-Small Cell Lung Cancer (NSCLC)
    Yeh, Norman
    Diot, Quentin
    Altoos, Basel
    Kavanagh, Brian
    Gaspar, Laurie
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S679 - S679
  • [26] Stereotactic Body Radiotherapy Versus Surgery for Early-Stage Non-Small-Cell Lung Cancer
    Li, Hui
    Shen, Yefeng
    Wu, Yuanzhou
    Cai, Shaoru
    Zhu, Yaru
    Chen, Siping
    Chen, Xin
    Chen, Qunqing
    [J]. JOURNAL OF SURGICAL RESEARCH, 2019, 243 : 346 - 353
  • [27] A phase I/II study on stereotactic body radiotherapy for stage I non-small cell lung cancer
    Koto, M.
    Takai, Y.
    Ogawa, Y.
    Ariga, H.
    Takeda, K.
    Sakayauchi, T.
    Narasaki, K.
    Jingu, K.
    Yamada, S.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 380 - 380
  • [28] Clinical Outcomes and Toxicity after Stereotactic Body Radiotherapy (SBRT) with or without Adjuvant Chemotherapy for Stage I Non-Small Cell Lung Cancer (NSCLC)
    Vance, S.
    Ye, H.
    Baschnagel, A.
    Mangona, V.
    Yan, D.
    Grills, I.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S292 - S293
  • [29] Health-related quality of life (HRQOL) after stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC).
    Senan, S.
    Gundy, C.
    Haasbeek, C. J.
    Slotman, B. J.
    Aaronson, N. K.
    Lagerwaard, F. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Diffusion of stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) in the Medicare population, 2007-2009.
    Yu, James B.
    Soulos, Pamela R.
    Cramer, Laura D.
    Decker, Roy H.
    Kim, Anthony W.
    Gross, Cary Philip
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345